Dosing and concentration
Adult experimental-use dose information: 200–500 micrograms at bedtime is not a universal prescription for energy or sleep. Your clinician should specify whether treatment is appropriate, its timing and when it will be reviewed.
Historical medical dosing addressed specific diagnostic or paediatric treatment purposes. Those amounts should not be turned into a weight-based adult anti-ageing calculator.
For prescribed treatment, record the actual amount, frequency and clinical reason. Do not infer a dose from vial size: a vial containing several milligrams may contain many administrations.
For arithmetic only, a documented final preparation of 5 mg in 2 mL contains 2.5 mg/mL, or 2,500 micrograms/mL. This explains concentration and does not specify the appropriate diluent, preparation volume or administration amount for a particular product.
If a syringe is marked in U-100 units, those are volume markings calibrated for insulin. They do not measure international units of sermorelin. Save the concentration with any calculated volume so it cannot silently carry over to a different vial strength.
Preparation and reconstitution
Sermorelin may be supplied as a lyophilised, or freeze-dried, preparation. Reconstitution dissolves it in a specified liquid. The appropriate diluent belongs to the formulation, not just to the peptide's name.
Bacteriostatic water contains a preservative, commonly benzyl alcohol. Some medicinal preparations specify a different liquid or immediate use after mixing. Follow those instructions rather than replacing them with a general rule about peptide water.
Before mixing, check the exact product, amount, diluent, volume and usable period after preparation. Use clean hands, a clean preparation area and sterile single-use equipment. Follow the specified mixing method; do not apply heat or add acid to rescue unexpected particles or incomplete dissolution.
Record the preparation date and final concentration clearly. Sterility and chemical stability are separate: a preservative does not prove the peptide remains potent, and a clear solution does not prove it is uncontaminated.
Administration
Injection under the skin means the fatty tissue beneath the skin. A prescribed product should be accompanied by teaching on site selection, the supplied device and appropriate technique. It is not an instruction to inject directly into a muscle or an area being rehabilitated.
Rotate suitable sites and avoid irritated, infected or bruised skin. Needle length, angle and whether a skin fold is needed depend on the person and device. Use new sterile equipment for each administration and discard it in a sharps container.
Follow the timing in your treatment plan. Do not add fasting rules, move doses to bedtime or take an extra amount after poor sleep without reviewing the change. Record missed or changed doses accurately.
Routes and bioavailability
Swallowed sermorelin faces digestive breakdown and limited passage across the gut lining. An oral or sublingual formulation therefore needs evidence for its own delivery method; it cannot inherit an injectable amount.
Subcutaneous delivery avoids the first digestive step, but it is still not identical to delivery into a vein. A historical medical monograph reports low absolute subcutaneous absorption into the bloodstream, illustrating why “injected” does not always mean complete systemic delivery.
Some oral peptides work locally in the gut despite low blood levels. Sermorelin is intended to signal the pituitary, so a local gut effect is not an established reason to prefer swallowing it. Claims of improved oral absorption should specify the formulation and measured outcome.
Half-life
Approximately 11–12 minutes after intravenous or injection under the skin in the historical medical monograph. The peptide's brief half-life is separate from the duration of the growth-hormone response.
This figure does not establish how frequently a patient should dose or how long a prepared vial can be stored.
Storage
Use the actual formulation's temperature, light protection and after-mixing instructions. Do not apply a universal 30-day refrigerated shelf life to every sermorelin preparation.
Record expiry, reconstitution and first-opening dates separately. Keep the product in its labelled container, avoid heat exposure and do not freeze unless specifically directed. Storage instructions for an unopened lyophilised vial may change once liquid has been added.
A damaged seal, uncertain temperature history, unexpected particles or changed appearance needs assessment. Extra bacteriostatic water, filtering or transferring to another container does not reliably correct those problems.
Contraindications and side effects
Growth-hormone treatment needs special review in patients with active cancer, pituitary or intracranial disease, abnormal glucose control and unexplained headaches or visual symptoms. A medical evaluation should establish why the hormone pathway is being targeted.
Local reactions, flushing and headache can occur. Growth-hormone-related effects can include swelling, joint discomfort, tingling and changes in glucose control. Thyroid status also matters when evaluating growth and hormone symptoms; a fatigue complaint should not automatically be attributed to low GH.
Pregnancy, breastfeeding and treatment of children require specialist review. Check steroid medicines, other hormone treatments and diabetes medicines together. Severe allergy or a severe headache with vision changes needs urgent attention.
Tracking progress and everyday questions
Track the goal, actual schedule, sleep, training and unwanted effects. Keep clinician-directed laboratory results with their dates and reference ranges. Avoid adjusting treatment from a single random GH result.
Is sermorelin the same as growth hormone? No; it stimulates release rather than supplying it. Does that make it automatically safe? No. Can you scale a child’s treatment dose to an adult? No; the condition and treatment plan are different.
If nothing meaningful improves, a longer cycle is not automatically the answer. Revisit the original problem and the other factors that could explain it.